vs
Esperion Therapeutics, Inc.（ESPR）与PROGRESS SOFTWARE CORP（PRGS）财务数据对比。点击上方公司名可切换其他公司
PROGRESS SOFTWARE CORP的季度营收约是Esperion Therapeutics, Inc.的1.5倍（$252.7M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 17.5%），过去两年PROGRESS SOFTWARE CORP的营收复合增速更高（17.0% vs 10.6%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
Progress Software是全球领先的企业级软件服务商，主营应用开发平台、数据连接工具、数字体验解决方案等产品，服务覆盖金融、医疗、制造、零售等多行业的全球企业客户，助力客户搭建高性能可扩展的业务应用，提升运营效率。
ESPR vs PRGS — 直观对比
营收规模更大
PRGS
是对方的1.5倍
$168.4M
营收增速更快
ESPR
高出126.2%
17.5%
两年增速更快
PRGS
近两年复合增速
10.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $252.7M |
| 净利润 | — | $25.7M |
| 毛利率 | — | 81.6% |
| 营业利润率 | 50.6% | 15.2% |
| 净利率 | — | 10.2% |
| 营收同比 | 143.7% | 17.5% |
| 净利润同比 | — | 2144.6% |
| 每股收益（稀释后） | $0.32 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRPRGS
| Q4 25 | $168.4M | $252.7M | ||
| Q3 25 | $87.3M | $249.8M | ||
| Q2 25 | $82.4M | $237.4M | ||
| Q1 25 | $65.0M | $238.0M | ||
| Q4 24 | $69.1M | $215.0M | ||
| Q3 24 | $51.6M | $178.7M | ||
| Q2 24 | $73.8M | $175.1M | ||
| Q1 24 | $137.7M | $184.7M |
净利润ESPRPRGS
| Q4 25 | — | $25.7M | ||
| Q3 25 | $-31.3M | $19.4M | ||
| Q2 25 | $-12.7M | $17.0M | ||
| Q1 25 | $-40.5M | $10.9M | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | $-29.5M | $28.5M | ||
| Q2 24 | $-61.9M | $16.2M | ||
| Q1 24 | $61.0M | $22.6M |
毛利率ESPRPRGS
| Q4 25 | — | 81.6% | ||
| Q3 25 | — | 81.0% | ||
| Q2 25 | — | 80.1% | ||
| Q1 25 | — | 80.6% | ||
| Q4 24 | — | 83.0% | ||
| Q3 24 | — | 83.7% | ||
| Q2 24 | — | 81.7% | ||
| Q1 24 | — | 82.2% |
营业利润率ESPRPRGS
| Q4 25 | 50.6% | 15.2% | ||
| Q3 25 | -11.4% | 17.6% | ||
| Q2 25 | 8.6% | 16.3% | ||
| Q1 25 | -34.0% | 13.6% | ||
| Q4 24 | -6.4% | 10.0% | ||
| Q3 24 | -31.0% | 22.6% | ||
| Q2 24 | 3.5% | 15.5% | ||
| Q1 24 | 52.5% | 19.0% |
净利率ESPRPRGS
| Q4 25 | — | 10.2% | ||
| Q3 25 | -35.9% | 7.8% | ||
| Q2 25 | -15.4% | 7.2% | ||
| Q1 25 | -62.2% | 4.6% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | -57.2% | 15.9% | ||
| Q2 24 | -83.9% | 9.2% | ||
| Q1 24 | 44.3% | 12.3% |
每股收益（稀释后）ESPRPRGS
| Q4 25 | $0.32 | $0.59 | ||
| Q3 25 | $-0.16 | $0.44 | ||
| Q2 25 | $-0.06 | $0.39 | ||
| Q1 25 | $-0.21 | $0.24 | ||
| Q4 24 | $-0.14 | $0.01 | ||
| Q3 24 | $-0.15 | $0.65 | ||
| Q2 24 | $-0.33 | $0.37 | ||
| Q1 24 | $0.34 | $0.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $94.8M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $-302.0M | $478.3M |
| 总资产 | $465.9M | $2.5B |
| 负债/权益比越低杠杆越低 | — | 2.93× |
8季度趋势，按日历期对齐
现金及短期投资ESPRPRGS
| Q4 25 | $167.9M | $94.8M | ||
| Q3 25 | $92.4M | $99.0M | ||
| Q2 25 | $86.1M | $102.0M | ||
| Q1 25 | $114.6M | $124.2M | ||
| Q4 24 | $144.8M | $118.1M | ||
| Q3 24 | $144.7M | $232.7M | ||
| Q2 24 | $189.3M | $190.4M | ||
| Q1 24 | $226.6M | $133.2M |
总债务ESPRPRGS
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ESPRPRGS
| Q4 25 | $-302.0M | $478.3M | ||
| Q3 25 | $-451.4M | $477.7M | ||
| Q2 25 | $-433.5M | $452.7M | ||
| Q1 25 | $-426.2M | $431.8M | ||
| Q4 24 | $-388.7M | $438.8M | ||
| Q3 24 | $-370.2M | $425.6M | ||
| Q2 24 | $-344.2M | $401.7M | ||
| Q1 24 | $-294.3M | $461.7M |
总资产ESPRPRGS
| Q4 25 | $465.9M | $2.5B | ||
| Q3 25 | $364.0M | $2.4B | ||
| Q2 25 | $347.1M | $2.4B | ||
| Q1 25 | $324.0M | $2.5B | ||
| Q4 24 | $343.8M | $2.5B | ||
| Q3 24 | $314.1M | $1.6B | ||
| Q2 24 | $352.3M | $1.6B | ||
| Q1 24 | $373.1M | $1.5B |
负债/权益比ESPRPRGS
| Q4 25 | — | 2.93× | ||
| Q3 25 | — | 2.97× | ||
| Q2 25 | — | 3.22× | ||
| Q1 25 | — | 3.50× | ||
| Q4 24 | — | 3.48× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $62.8M |
| 自由现金流经营现金流 - 资本支出 | — | $59.9M |
| 自由现金流率自由现金流/营收 | — | 23.7% |
| 资本支出强度资本支出/营收 | 0.0% | 1.1% |
| 现金转化率经营现金流/净利润 | — | 2.44× |
| 过去12个月自由现金流最近4个季度 | — | $229.5M |
8季度趋势，按日历期对齐
经营现金流ESPRPRGS
| Q4 25 | $45.2M | $62.8M | ||
| Q3 25 | $-4.3M | $73.4M | ||
| Q2 25 | $-31.4M | $30.0M | ||
| Q1 25 | $-22.6M | $68.9M | ||
| Q4 24 | $-35.0M | $19.7M | ||
| Q3 24 | $-35.3M | $57.7M | ||
| Q2 24 | $-7.2M | $63.7M | ||
| Q1 24 | $53.8M | $70.5M |
自由现金流ESPRPRGS
| Q4 25 | — | $59.9M | ||
| Q3 25 | — | $72.4M | ||
| Q2 25 | — | $29.5M | ||
| Q1 25 | — | $67.7M | ||
| Q4 24 | — | $16.8M | ||
| Q3 24 | $-35.5M | $56.6M | ||
| Q2 24 | $-7.3M | $62.7M | ||
| Q1 24 | $53.8M | $70.2M |
自由现金流率ESPRPRGS
| Q4 25 | — | 23.7% | ||
| Q3 25 | — | 29.0% | ||
| Q2 25 | — | 12.4% | ||
| Q1 25 | — | 28.4% | ||
| Q4 24 | — | 7.8% | ||
| Q3 24 | -68.7% | 31.7% | ||
| Q2 24 | -9.9% | 35.8% | ||
| Q1 24 | 39.0% | 38.0% |
资本支出强度ESPRPRGS
| Q4 25 | 0.0% | 1.1% | ||
| Q3 25 | 0.0% | 0.4% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.0% | 0.5% | ||
| Q4 24 | 0.0% | 1.3% | ||
| Q3 24 | 0.3% | 0.6% | ||
| Q2 24 | 0.1% | 0.5% | ||
| Q1 24 | 0.1% | 0.2% |
现金转化率ESPRPRGS
| Q4 25 | — | 2.44× | ||
| Q3 25 | — | 3.78× | ||
| Q2 25 | — | 1.76× | ||
| Q1 25 | — | 6.30× | ||
| Q4 24 | — | 17.13× | ||
| Q3 24 | — | 2.03× | ||
| Q2 24 | — | 3.93× | ||
| Q1 24 | 0.88× | 3.11× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
PRGS
| Maintenanceand Services | $187.5M | 74% |
| Share File Acquisition | $67.5M | 27% |
